Navigation Links
Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
Date:10/20/2007

LAKE ZURICH, Ill., Oct. 20 /PRNewswire/ -- Fenwal, Inc. today announced a new partnership with Data Innovations, Inc. to develop, distribute and license a data capture and reporting system for Fenwal's automated blood component collection systems. This collaboration will allow blood centers to export data from Fenwal's automated blood collection devices into The Instrument Manager(TM) system that will generate standard and customized reports analyzing critical donor and procedural information.

A data capture and reporting system will help blood centers drive operational efficiencies by eliminating the need to manually capture this information from Fenwal's automated collection devices. It will also allow blood centers to more easily identify and track donor and procedure trends, further improving their collection management efforts. Fenwal will begin offering a data capture and reporting system with Data Innovations in 2008 for its ALYX, AMICUS and Autophersis-C automated collection devices in the United States, and will then expand this offering to Europe and other regions.

"As an independent company entirely focused on the transfusion medicine community, Fenwal is committed to investing in research and development programs that will bring the best portfolio of products and solutions to our customers," said Ron K. Labrum, Fenwal President and CEO. "When our needs require that we go outside the company for specific expertise, Fenwal will partner with other world-class leaders, such as Data Innovations, to help us meet and exceed our customers' needs and expectations."

Fenwal selected Data Innovations for this collaboration due to the company's unique middleware expertise, which is software that both connects separate instruments and systems and allows them to communicate with each other and helps the lab manage that data to streamline workflows. Future integrated data management solutions Fenwal will introduce with Data Innovations include: interfaces to donor information/management systems, remote services diagnostics and more.

"We have been looking to expand and add efficiencies in the blood and plasma center value chain," said Gregory Vail, President of Data Innovations. "Fenwal is a respected, global leader in the transfusion medicine community and their broad product offering, commitment to innovation, and strong customer relationships made them a clear choice to partner with in bringing data management solutions to this industry."

Fenwal is a leading, global healthcare company focused on the development, manufacture and marketing of products and services for the transfusion medicine industry. The company provides a comprehensive portfolio of products and services for manual and automated blood collection, processing and storage. For more information, please visit http://www.fenwalinc.com.

Data Innovations is the world's largest clinical laboratory middleware company offering comprehensive solutions encompassing pre-analytical, analytical, and post analytical process improvement. For more information, please visit http://www.datainnovations.com.


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: